Objective: To use multimodal neuroimaging to evaluate the influence of heterogeneous underlying pathology in corticobasal syndrome (CBS) on the neuroanatomical distribution of disease.Methods: We performed a retrospective evaluation of 35 patients with CBS with T1-weighted MRI, diffusion tensor imaging, and neuropathologic, genetic, or CSF evidence of underlying pathology. Patients were assigned to 2 groups: those with evidence of Alzheimer pathology (CBS-AD) and those without Alzheimer pathology (CBS-non-AD). Group comparisons of CBS-AD and CBS-non-AD assessed clinical features, gray matter (GM) cortical thickness, and white matter (WM) fractional anisotropy.Results: CBS-AD was found in 34% (n 5 12) and CBS-non-AD in 66% (n 5 23) of CBS patients.Clinical evaluations revealed that CBS-non-AD had a higher frequency of asymmetric rigidity compared to CBS-AD, but groups otherwise did not differ in dementia severity, impairments in cognition, or rates of extrapyramidal symptoms. We found frontoparietal GM and WM disease in each group compared to healthy, demographically comparable controls, as well as multimodal neuroimaging evidence of a double dissociation: CBS-non-AD had WM disease in the corpus callosum, corticospinal tract, and superior longitudinal fasciculus relative to CBS-AD, and CBS-AD had reduced temporoparietal GM relative to CBS-non-AD, including the precuneus and posterior cingulate.
Conclusions:Patients with CBS have a pathology-mediated dissociation of GM and WM disease.Multimodality neuroimaging may be useful for improving in vivo pathologic diagnosis of CBS. Corticobasal syndrome (CBS) is a neurodegenerative condition characterized by lateralized extrapyramidal features and cortically mediated cognitive dysfunction.1 The underlying pathology of CBS is heterogeneous, and clinical features appear to be insufficient to identify an individual's histopathologic abnormality during life.2,3 The most common neuropathologic causes of CBS include corticobasal degeneration, a 4-repeat form of tau pathology associated with frontotemporal lobar degeneration (FTLD), 4 and Alzheimer disease (AD). 2,5,6 Multimodal neuroimaging studies suggest that AD and FTLD can be dissociated on the basis of gray matter (GM) and white matter (WM) neuroimaging. 7,8 Specifically, GM atrophy was evident in both AD and FTLD in T1-weighted MRI studies, but diffusion tensor imaging (DTI) revealed more WM disease in FTLD than in AD. Additional neuroimaging evidence suggests that tau pathology, the most common form of underlying pathology in CBS, is associated with substantial WM imaging changes 9 and that these findings converge with neuropathologic evidence of WM disease burden in 4-repeat tauopathy.9,10 However, prior evidence of greater WM pathology in FTLD disorders has been based on clinically heterogeneous study samples; therefore, it is not clear whether a dissociation of GM and WM disease is